Gufic BioSciences schedules AGM, reports strong financial performance

Gufic BioSciences Limited announced its 41st Annual General Meeting (AGM) will be held virtually on Monday, September 29, 2025, at 3:30 P.M. (IST) to approve the annual report for the financial year 2024-2025. The company reported a total revenue from operations of INR 81,980.60 Lakhs for FY 2024-25, an increase from INR 80,666.57 Lakhs in the previous year. The board recommended a final dividend of Re. 0.10 per equity share for FY 2024-25.

The company's audited standalone financial statements for FY 2024-25 were approved on May 30, 2025, by the board of directors, showing a profit after tax of INR 6,993.28 Lakhs. The AGM notice includes the re-appointment of Mr. Jayesh P. Choksi as chairman & managing director. Additionally, the company is seeking ratification for the remuneration of M/s. Poddar & Co. as cost auditors for FY 2024-25 and FY 2025-26, and M/s. Manish Ghia & Associates as secretarial auditors for FY 2025-26.

Gufic BioSciences highlighted its commitment to sustainability, with its Business Responsibility & Sustainability Report also forming part of the annual report. The total dividend payout for the financial year ending March 31, 2025, will amount to ₹1,00,27,750.60.